Phathom Pharmaceuticals, Inc. (PHAT) KPIs and segments

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30

$6.06−0.17 (-2.73%)

Close on Nov 13, 2026Market cap $492.63MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Phathom Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Phathom Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?